Target intelligence / Profile preview

Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (ALKBH6)

Target
ALKBH6
Molecular classification
Enzyme, Dioxygenase, Alpha-ketoglutarate-dependent dioxygenase, Nucleic acid demethylase (probable)
01

Overview

Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (ALKBH6) is a human enzyme belonging to the AlkB family of Fe(II)/alpha-ketoglutarate-dependent dioxygenases. It features a characteristic double-stranded beta-helix (DSBH) fold and several unique structural elements (notably the Flip1, Flip2, and Flip3 domains) that influence substrate specificity. ALKBH6 is implicated in the direct repair of alkylated nucleic acids, likely through demethylation reactions that reverse nucleic acid methylation damage. While its exact physiological substrates remain unidentified, ALKBH6 shows a preference for single-stranded nucleic acids. Functionally, it participates in maintenance of genomic stability and has a role in tumor suppression, as loss or mutation of ALKBH6 leads to increased DNA damage sensitivity and is linked to poor cancer outcomes. The protein interacts with histone modification reader ZMYND11, suggesting a cross-talk between RNA/DNA modification and epigenetic regulation. No direct drugs or inhibitors are currently documented for ALKBH6, but its role in cancer biology and DNA repair marks it as a molecule of potential therapeutic interest.

Other names
AlkB homolog 6Probable RNA/DNA demethylase ALKBH6ABH6MGC15677Alkylated DNA repair protein alkB homolog 6Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6Probable nucleic acid dioxygenase ALKBH6Putative RNA/DNA demethylase ALKBH6Alkylation repair homolog 6
02

Mechanism of action

Not established for drugs, but the enzyme putatively acts by catalyzing demethylation of nucleic acids using Fe(II) and alpha-ketoglutarate as cofactors

03

Biological functions

DNA repairRNA modification/demethylation (probable)Maintenance of genomic stabilityEpigenetic regulation
04

Disease associations

CancerTumor suppressionGenomic instability (via DNA damage response)
05

Safety considerations

Not specifically reported, but functional loss or mutations of ALKBH6 are associated with genomic instability and potentially increased cancer risk
06

Interacting drugs

None are currently reported in the literature or research databases for direct pharmacological targeting of ALKBH6
07

Biomarkers

There is evidence that ALKBH6 expression level may serve as a prognostic biomarker in cancers such as pancreatic cancer, where higher expression correlates with better outcomes

Beyond the preview

Go deeper on Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (ALKBH6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (ALKBH6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call